Concepedia

Jana Stojanova

JS

Statistics

Publications

5

Citations

165

H-Index

5

Active since

2015

Affiliations

University of Chile(Current)

Inserm

St Vincent's Clinic

UNSW Sydney

St Vincent's Hospital Sydney

Jana Stojanova is an author at University of Chile specializing in drug resistance, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2015–2024

5

Publications

5

Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections

Fabien Lamoureux, Thomas Duflot, Jean‐Baptiste Woillard et al. · International Journal of Antimicrobial Agents · 2015 · 102 citations · Full text

, , +13

Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses

Nelson Varela, Luis A. Quiñones, Jana Stojanova et al. · Pharmacological Research · 2015 · 28 citations · Full text

, , +10

A Candidate Gene Approach of the Calcineurin Pathway To Identify Variants Associated with Clinical Outcomes in Renal Transplantation

Lucie Pouché, Matthias Koitka, Jana Stojanova et al. · Pharmacogenomics · 2016 · 14 citations · Full text

A potential novel treatment for cirrhosis‐related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease

I. Shen, Jana Stojanova, Malcolm Guan Hin Yeo et al. · British Journal of Clinical Pharmacology · 2024 · 11 citations · Full text

Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey

Jingjing Hou, Debbie Marriott, Dario Cattaneo et al. · Frontiers in Pharmacology · 2022 · 10 citations · Full text

1–5 of 5